Eisler Capital (Us) LLC Madrigal Pharmaceuticals, Inc. Transaction History
Eisler Capital (Us) LLC
- $5.6 Trillion
- Q2 2024
A detailed history of Eisler Capital (Us) LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Eisler Capital (Us) LLC holds 2,885 shares of MDGL stock, worth $921,988. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,885Holding current value
$921,988% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
294Shares Held
21.8MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$794 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$657 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$631 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$612 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$591 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.47B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...